Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/12/2003

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

31/12/2003
Quarter4
Financial Year End31/12/2003
The figureshave been audited

Attachments

pharma_klse0312.doc
228 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2003


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
31/12/2003 
31/12/2002 
31/12/2003 
31/12/2002 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
166,617
129,787
632,604
585,237
2Profit/(loss) before tax
18,664
11,287
66,841
61,170
3Profit/(loss)
after tax and minority
interest
9,495
6,779
40,756
37,341
4Net profit/(loss) for
the period
9,495
6,779
40,756
37,341
5Basic earnings/(loss) per share (sen)
9.47
6.78
40.70
37.34
6Dividend per share (sen)
12.00
6.00
12.00
8.50



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net tangible assets per share (RM)

2.2200
1.8000

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
The Board of Directors of Pharmaniaga Berhad recommends a final tax exempt dividend of 8.5 sen per share. The dates of entitlement and payment will be announced at a later date.


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced19 Feb 2004  
CategoryFinancial Results
Reference NoCC-040217-40807